Evidence map›Paper›PMID 40553202›Full record

ArticleHistochemistry and cell biology2025

Citric acid as a safe alternative to oxalic acid in the Gomori reticulin technique: a comparative study.

Ana Bento, Ana Nascimento, Sofia Nobre, Teresa Ferreira, Amadeu Borges-Ferro, Ana Marques-Ramos

Abstract readComparative Study
In one paragraph

Article in Histochemistry and cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana Bento *Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa (ESTeSL), Av. D. João II, Lote 4.69.01, 1990-096, Lisbon, Portugal.
Ana Nascimento *Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa (ESTeSL), Av. D. João II, Lote 4.69.01, 1990-096, Lisbon, Portugal.
Sofia Nobre *Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa (ESTeSL), Av. D. João II, Lote 4.69.01, 1990-096, Lisbon, Portugal.
Teresa FerreiraInstituto Português de Oncologia Francisco Gentil, Lisbon, Portugal.
Amadeu Borges-FerroEscola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa (ESTeSL), Av. D. João II, Lote 4.69.01, 1990-096, Lisbon, Portugal.
Ana Marques-RamosEscola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa (ESTeSL), Av. D. João II, Lote 4.69.01, 1990-096, Lisbon, Portugal. ana.ramos@estesl.ipl.pt.ORCID http://orcid.org/0000-0003-2655-8806

Funding

Fundação para a Ciência e a Tecnologia UIDB/05608/2020 and UIDP/05608/2020.
6 · The paper itself

Abstract

The use of oxalic acid is common in metallic impregnation techniques, where it serves as a reducing and bleaching agent for potassium permanganate. Given that oxalic acid is harmful to health, its replacement with another reagent is advantageous for healthcare professionals handling it in laboratory settings. Considering that citric acid can also reduce potassium permanganate, the aim of this study was to determine whether oxalic acid in the Gomori reticulin technique could be replaced by citric acid, a compound substantially less hazardous to health. To this end, 1%, 5%, and 10% citric acid solutions were tested on porcine liver and kidney samples, and the intensity of reticulin fiber staining, contrast, and overall morphological preservation were assessed in comparison with 1% oxalic acid. The results showed no statistically significant differences between the positive control (oxalic acid) and the citric acid protocols, with the 5% citric acid concentration proving most favorable in terms of required incubation time and the evaluated morphological parameters. It was therefore concluded that citric acid can be used as a bleaching agent for potassium permanganate in the Gomori technique, effectively replacing oxalic acid.

Indexed as

Citric AcidOxalic AcidAnimalsKidneyLiverSwineCitric AcidOxalic AcidCitric acidGomori reticulinOxalic acid substitutionPotassium permanganate

Identifiers

PMID40553202
PMCPMC12187824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.